LNA Sante SA (FR:LNA)
:LNA
Top Page
LNA Sante SA
(LNA)
Select Model
Select Model
Rating:67Neutral
Price Target:
€29.00
▲(18.37% Upside)
Action:ReiteratedDate:03/29/26
The score is driven primarily by solid operating/cash-flow performance and a very attractive valuation, offset by meaningful balance-sheet leverage and only modestly positive (not strong) technical momentum.
Positive Factors
Cash generation
Consistent positive operating and free cash flow provides durable internal funding for operations, maintenance and selective capex. Over a 2–6 month horizon this underpins liquidity, supports debt servicing and reduces reliance on external financing.
Negative Factors
High leverage
A debt-to-equity ratio near 3x leaves the company materially exposed to refinancing risk and interest-rate moves. Over the medium term this constrains financial flexibility, raises fixed costs, and can force deleveraging if earnings or cash flow weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistent positive operating and free cash flow provides durable internal funding for operations, maintenance and selective capex. Over a 2–6 month horizon this underpins liquidity, supports debt servicing and reduces reliance on external financing.
Read all positive factors
LNA Sante SA (LNA) vs. iShares MSCI France ETF (EWQ)
Market Cap
€289.68M
Dividend Yield2.73%
Average Volume (3M)3.16K
Price to Earnings (P/E)10.4
Beta (1Y)0.37
Revenue Growth13.31%
EPS Growth-13.07%
CountryFR
Employees9,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.25
Shares Outstanding10,709,416
10 Day Avg. Volume3,290
30 Day Avg. Volume3,156
Financial Highlights & Ratios
PEG Ratio1.01
Price to Book (P/B)0.76
Price to Sales (P/S)0.28
P/FCF Ratio4.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€35.00Price Target Upside42.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.68
Revenue Forecast (FY)€985.13M
LNA Sante SA Business Overview & Revenue Model
Company Description
LNA Santé SA engages in the management and operation of health establishments. The company operates retirement homes, medical and rehabilitation care, home hospital, mental health clinic, and health center. LNA Santé SA was founded in 1990 and is ...
LNA Sante SA Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
44
Neutral
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 912.67M | 806.60M | 736.09M | 728.22M | 689.49M |
| Gross Profit | 102.28M | 91.10M | 241.09M | 622.42M | 577.87M |
| EBITDA | 160.59M | 144.85M | 144.63M | 141.82M | 131.64M |
| Net Income | 24.14M | 21.82M | 23.41M | 25.81M | 23.51M |
Balance Sheet | |||||
| Total Assets | 1.60B | 1.54B | 1.51B | 1.51B | 1.53B |
| Cash, Cash Equivalents and Short-Term Investments | 94.83M | 75.06M | 77.17M | 101.98M | 152.12M |
| Total Debt | 907.25M | 936.51M | 887.67M | 911.55M | 1.00B |
| Total Liabilities | 1.26B | 1.21B | 1.20B | 1.21B | 1.31B |
| Stockholders Equity | 330.25M | 313.81M | 299.24M | 289.33M | 216.09M |
Cash Flow | |||||
| Free Cash Flow | 59.30M | 71.24M | 84.56M | 89.86M | 65.98M |
| Operating Cash Flow | 70.42M | 82.06M | 97.50M | 103.20M | 79.92M |
| Investing Cash Flow | -14.21M | -23.72M | -15.69M | -41.99M | -27.65M |
| Financing Cash Flow | -36.50M | -88.80M | -106.69M | -110.88M | -21.53M |
LNA Sante SA Technical Analysis
Positive
24.50
Price Trends
25.60
Positive
24.72
Positive
25.70
Positive
Market Momentum
0.51
Negative
69.92
Neutral
89.18
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:LNA, the sentiment is Positive. The current price of 24.5 is below the 20-day moving average (MA) of 26.27, below the 50-day MA of 25.60, and below the 200-day MA of 25.70, indicating a bullish trend. The MACD of 0.51 indicates Negative momentum. The RSI at 69.92 is Neutral, neither overbought nor oversold. The STOCH value of 89.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:LNA.
LNA Sante SA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | €289.68M | 10.41 | 6.64% | 2.73% | 13.31% | -13.07% | |
64 Neutral | €570.78M | 10.15 | 16.40% | 2.85% | 4.45% | -14.08% | |
60 Neutral | €1.13B | -7.25 | -4.36% | ― | 4.70% | -0.37% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | €2.21B | -6.61 | -13.50% | ― | 6.30% | -100.37% | |
48 Neutral | €107.67M | -1.20 | ― | ― | 52.55% | -5.97% | |
47 Neutral | €1.32B | 873.33 | -1.70% | ― | 1.98% | 85.87% |
* General Sector Average
FR:LNA
LNA Sante SA
27.80
7.03
33.85%
FR:CLARI
Clariane
3.69
0.09
2.44%
FR:EMEIS
Orpea SA
13.70
3.55
34.95%
FR:EQS
Equasens
38.00
5.84
18.16%
FR:GDS
Ramsay Generale de Sante
10.25
0.63
6.55%
FR:MAAT
MaaT Pharma
5.72
-0.46
-7.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.